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Background: The aim of the present work was to evaluate the impact of xerostomia on the quality of life of patients 
who underwent radiotherapy in the head and neck region.
Material and Methods: This was a cross-sectional, quantitative study. The sample comprised 40 patients whose 
xerostomia was classified through the xerostomia inventory and the quality of life evaluated through the oral 
health impact profile questionnaire (OHIP).
Results: The majority of participants were male (75%), mean age 58.7 years. According to the degree of severity of 
the xerostomia, the average score among the participants was 36 points, this being considered moderate xerosto-
mia. A significant impact was observed, with the median score 11 points, with the highest scores in the domains 
related to functional limitation, physical pain and physical disability. The majority of the participants (97.5%) had 
reduced salivary flow after the end of radiotherapy. There was a significant positive correlation between the degree 
of xerostomia and reduced quality of life, Pearson correlation 0.5421, (p<0.05).
Conclusion: Based upon the results it is concluded that xerostomia has a negative impact on the quality of life of 
patients who undergo radiotherapy in the head and neck region.
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Introduction
Radiotherapy (RT) and surgery are described as standard 
therapies for early and locally advanced malignant tumors 
in the head and neck region. For advanced tumors, con-
comitant radiochemotherapy has also been used (1). De-
spite being one of the most used treatments, radiotherapy 
still produces important acute and long-term side effects 
for the oral cavity (2). Radiotherapy in the head and neck 
region is typically associated with toxicities that can have 
profound effects on the patient’s quality of life. Among the 
most common are mucositis, xerostomia, dysgeusia, dys-
phagia, trismus, dermatitis and candidiasis (3). 
Xerostomia is the most common oral complication of 
RT when the irradiated area involves the oral and maxil-
lofacial complex, which may occur both during or after 
radiotherapy (4,5). Radiation-induced xerostomia de-
pends on the cumulative doses of radiation on the head 
and neck region, in the first week of conventional RT, 
salivary flow decreases from 50 to 60%, after 7 weeks it 
diminishes to approximately 20% and continues to de-
cline for up to several months after RT (2). 
Damage to the salivary glands has generally shown a 
reduction in salivary flow, which can translate into a 
subjective sensation dry mouth (xerostomia), taste dis-
turbance, difficulty speaking, swallowing, chewing and 
increased risk of caries, pain and burning of the mouth, 
all of which culminates in negative consequences on the 
quality of life (4,6,7). A variety of methods are currently 
available for the evaluation of radiation-induced xero-
stomia, however, dry mouth is a subjective experience 
and its assessment should rely on patient self-reports (8).
Over the last decade, there has been an increase in the 
use of quality of life measures in clinical trials. Many 
instruments were designed to measure the impact of 
oral health on quality of life. Slade and Spencer intro-
duced the Oral Health Impact Profile (OHIP-49), a ques-
tionnaire containing 49 questions that capture seven 
conceptually formulated dimensions (functional limita-
tion, physical pain, psychological discomfort, physical 
disability, social disability, and incapacity) (9). In 1997, 
Slade published a reduced questionnaire with the same 
dimensions (OHIP-14) that confirmed results comparable 
to those obtained with the original OHIP-49 (10). The 
OHIP-14, the abbreviated form of OHIP-49, is reported 
as a useful instrument for use in clinical environment 
with good reliability, validity and precision (10,11).
The evaluation of the effect of oral diseases and social 
conditions may be of great value to researchers, and 
studies on quality of life may guide practitioners to 
most effective treatments in patients with cancer (12). In 
view of the above, it is observed that studies that evalu-
ate xerostomia and its consequences are of considerable 
importance, since it is a complex condition may have 
negative effects on the quality of life of individuals who 
need to undergo radiotherapy in the head and neck re-
gion. Thus, the present study aimed to evaluate the im-
pact of xerostomia on the quality of life of patients who 
underwent radiotherapy in the head and neck region.
Material and Methods
The study was an analytical cross-sectional with quan-
titative approach whose sample comprised 40 patients 
treated at a referral hospital in the state of Pernambuco 
(Brazil), from July to November of 2016. All patients 
were submitted to radiotherapy in the head and neck 
region and complained of xerostomia when first seen 
at the dental clinic of the hospital. Among the inclu-
sion criteria of the study were the minimum age of 18 
years and diagnosis of malignant neoplasia in the head 
and neck region. In addition, patients should have been 
treated with two-dimensional radiotherapy alone or 
concomitantly with chemotherapy or adjuvant surgery, 
the total dose should be equal to or greater than 50Gy 
and the treatment should include the larger salivary 
glands, oral cavity or oropharynx. Patients with other 
possible causal factors of xerostomia, such as those 
with diabetes mellitus, autoimmune, infectious and col-
lagen diseases, and patients who used drugs that could 
interfere with salivary flow (antidepressants, benzodi-
azepines, anti- hypertensives, among others). Patients 
with indication for palliative radiotherapy or who were 
unable to answer the questions were also excluded.
Xerostomia was evaluated using the translated and 
adapted version of the Xerostomia Inventory (XI), vali-
dated by Mata et al., originally developed by Thomson 
et al. (13,14). This is a questionnaire composed of 11 
questions that contemplates the symptomatological and 
behavioral aspects of xerostomia. For each of the 11 
items, there are five response options, which indicates 
how often each of the reported symptoms has occurred 
in the last four weeks. Each answer has a value: the an-
swer ‘Never’ is 1, ‘Almost never’ is 2, ‘Occasionally’ is 
3, ‘Relatively often’ is 4, and ‘Frequently’ is 5. At the 
end, the scores are summed and generate a single value 
between 11 and 55, 11 being classified as mild xerosto-
mia and 55 severe xerostomia.
Sialometry with determination of unstimulated salivary 
flow (USF) was also performed using the technique 
described by Sreebny and Vissink (15). Values above 
0.25 ml/min of USF were considered normal. All saliva 
collected in five minutes was conditioned in a heavy 
disposable container before and after the start of collec-
tion. For the calculation of total salivary flow, assuming 
that 1g of saliva corresponds to 1 ml, the following con-
version formula was used (15,16).
Salivary flow (ml/ min) = [Weight of tube after (g) – 
Weight of tube before (g)] / Time of saliva collection (min).
After the xerostomia was measured and sialometry 
was performed, a clinical examination of the oral cav-
ity was carried out, in order to evaluate the presence of 
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mucosal lesions, osteoradionecrosis and caries on the 
cervical, incisal or root regions. For the data collection, 
a questionnaire was initially used with questions ad-
dressing socio-demographic aspects in order to present 
the patient profile, and for the analysis of the quality of 
life, the summarized version of the Oral Health Impact 
Profile (OHIP 14) was used, translated and adapted into 
portuguese, proposed by Slade in 1997 and validated by 
Oliveira and Nadanovsky in 2005 (10,12).
The OHIP-14 instrument consists of seven dimensions: 
Functional Limitation, Physical Pain, Psychological 
Discomfort, Physical Inability, Psychological Inabil-
ity, Social Inability and Incapacity. There are five an-
swer options with a code for the 14 questions: ‘Never’ 
is worth 0 point, ‘Rarely’ 1 point, ‘Sometimes’ 2, ‘Re-
peatedly’ 3, and ‘Always’ is worth 4. In the OHIP-14 
the scale ranges from 0 to 56 points, and the higher the 
score, the worse the quality of life is (10).
For statistical analysis, the data were described with 
frequency distributions for the categorical variables 
and with medians and respective standard deviation 
when the quantitative variable presented normal dis-
tribution, otherwise the mean and interquartile range 
were presented. In the analysis of the association of the 
time of therapy and explanatory variables the Fischer 
Chi-Square test were applied in the comparison of cat-
egorical variables and for the quantitative variables the 
ANOVA test was applied, with Bonferroni post-test for 
the comparison of means, and Kruskall-Wallis test for 
the comparison of medians. A Pearson correlation mea-
sure was estimated and the hypothesis in the analysis of 
the relation between the degree of xerostomia and qual-
ity of life of the patients was tested. The statistical sig-
nificance adopted in the study was 5% (p<0.05) and the 
software used in the analysis was STATA version 12.0.
This study was approved by the Ethics and Research 
Committee of the Pernambuco Society against Cancer, 
with certification number 1.602.883.
Results
The study included 40 patients, most of whom were 
male (75%), with a mean of 58.7 years of age. Stratified 
in age groups, 57.5% of patients were between 50 and 
64 years of age. Regarding the origin of the patients, 
42.5% were residing in the countryside of the state 
of Pernambuco, Most of the patients were retired and 
17.5% had agriculture as occupation (Table 1).
Regarding the clinical aspects of the patients (Table 2), 
the most common type of neoplasm was oral squamous 
cell carcinoma OSCC (82.5%), 40% of the tumors were 
located in the oropharynx and 32.5% in the oral cavity. 
Alterations in oral cavity were observed in half of the 
patients, caries of radiation being the most frequent al-
teration (60%). Out of the 40 patients studied, 28 (70%) 
had chemotherapy associated with radiotherapy.
Table 1:  Sociodemographic profile of patients with diagnosis of ma-
lignant lesions in the head and neck region treated at Hospital de 
Cancer de Pernambuco.
Characteristics sociodemographic Number (%)
Age (in years)a 58.7 ± 9.5 (32; 78)
Age group
Under 50 years 6 (15.0%)
50-64 years old 23 (57.5%)










Farmer 7 (17.5%) 
General Service Assistant 4 (10.0%)
Salesman 3 (7.5%)
Others 9 (22.5%)
a Mean ± standard deviation (maximum; Minimum)
Regarding the time of conclusion of radiotherapy, most 
participants (45%) had between 7 and 18 months. Re-
garding the degree of severity of the xerostomia, the av-
erage score among the participants was 36 points. It was 
observed that 39 (97.5%) of the patients had a decrease 
in salivary flow, whereas only one patient had a normal 
salivary flow, that is, a flow above to 0.25 ml/min (Table 
2). Regarding the quality of life (Fig. 1), the median 
OHIP-14 score of the respondents was 11 points, with 
a minimum score of zero and a maximum of 37 points, 
with the majority of participants having a score above 
the median, demonstrating a significant negative impact 
on the quality of life of these patients.
Fig. 1: Overall mean score of the oral health impact profile (OHIP-
14) of patients diagnosed with malignant lesions in the head and 
neck region treated at the Hospital de Cancer de Pernambuco.
* OHIP-14 general: Ma = 11 (P25 = 6; P75 = 18)
 minimum = 0 and maximum = 37
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Analyzing the scores on the quality of life scale through 
the oral health impact profile (Fig. 2), we observed that 
questions 2 (“Did you feel that the taste of food has 
gotten worse?”), 4 (“Did you feel uncomfortable eat-
ing any food? “) and 7 (“Has your food intake gotten 
impaired?”) were the ones with a higher frequency of 
answers “always” or “repeatedly” between those sur-
veyed. However the questions 9 (“Did you find it dif-
ficult to relax?”), 10 (“Did you feel embarrassed?”) and 
14 (“Have you become totally unable to do your daily 
activities?”) were the ones with a lower frequency of 
answers “always” or “repeatedly”. This reflects in the 
analysis by domains where the highest scores, and con-
sequently a worse quality of life, are in the domains re-
lated to functional limitation, physical pain and physi-
cal disability (Fig. 3).
Regarding the influence of xerostomia on patients’ 
quality of life, it was observed that there was a positive 
correlation when Pearson’s correlation was performed 
Clinical features Statistic
Tumor diagnosis
Squamous cell carcinoma 33 (82.5%)
Mucinous adenocarcinoma 2 (5.0%)
Cystic adenoid carcinoma 2 (5.0%)
Dermatofibrosarcoma 1 (2.5%)
Lymphoepithelioma 2 (5.0%)
 Location of Tumor
Oropharynx 16 (40.0%)
Oral cavity 13 (32.5%)


















End of radiotherapy (in months)
Median (P25; P75) 10.5 (5.5; 20,5)
Categorized
From 1 to 6 months 11 (27.5%)
From 7 ato18 months 18 (45.0%)
19 months or more 11 (27.5%)
Severity of Xerostomia
Mean ± sd (minimum, maximum) 34.0 ± 6.8 (15; 48)
Salivary flow rate at rest (in ml / min)
Median (P25; P75) 0.005 (0; 0.06) 
Salivary flow equal to zero 20 (50.0%)
Low flow (up to 0.25) 19 (47.5%)
Normal  flow (> 0.25) 1 (2.5%)
a Non exclusive
Table 2:  Clinical aspects of patients diagnosed with malignant le-
sions in the head and neck region treated at Hospital de Cancer de 
Pernambuco.
Fig. 2: Percentage distribution of the quality of life related issues of 
the oral health impact profile (OHIP-14) of patients diagnosed with 
malignant lesions in the head and neck region treated at Hospital de 
Câncer de Pernambuco.
Q1. Did you have trouble speaking a word?
Q2. Did you feel that the taste of food has gotten worse?
Q3. Did you feel any pain in your mouth or in your teeth?
Q4. Did you feel uncomfortable eating some food?
Q5. Were you worried?
Q6. Did you feel stressed?
Q7. Has your food been harmed?
Q8. Did you have to stop your meals?
Q9. Did you find it difficult to relax?
Q10. Did you feel ashamed?
Q11. Were you angry with other people?
Q12. Did you have difficulty performing your daily activities?
Q13. Did you feel that life, in general, got worse?
Q14. Were you totally unable to do your daily activities?
Fig. 3: Mean score of the oral health impact profile (OHIP-14) by 
domain of patients diagnosed with malignant lesions in the head and 
neck region treated at the Hospital de Cancer de Pernambuco.
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(r = 0.5421; p<0.05), thus demonstrating that there was 
an influence of xerostomia in the decrease of quality 
of life of the patients studied. Stratified by the time of 
conclusion of radiotherapy, this correlation is statisti-
cally significant in patients with more than 6 months 
of radiotherapy, with values equal to 0.6680 (p<0.05) 
and 0.6031 (p<0.05) for patients with time of conclusion 
between 7 and 18 months and over 18 months, respec-
tively.
Discussion
Xerostomia is the most common oral complication in 
patients who undergo radiotherapy of the head and neck 
and may appear during or after radiotherapy (4,17). The 
duration and intensity of these effects are determined 
by factors such as dose per fraction, total dose of ra-
diation, volume of irradiated gland, dose distribution in 
tissue volume and association with chemotherapy (18). 
Corroborating with the literature, in this study more 
than half of the patients who presented with xerostomia 
received radiation in the oral cavity and oropharynx re-
gion, covering the major salivary glands.
Several authors affirm that hypofunction of the salivary 
gland caused by radiotherapy in the head and neck is 
a strongly associated factor in the etiology of xerosto-
mia (17,19,20). Tiwana et al. in a study of patients with 
head and neck cancer after conventional radiotherapy 
observed that there was a decline in the salivary flow 
of patients during radiotherapy and that after 6 months 
of treatment, 39% of the patients had a stimulated sali-
vary flow smaller than 0.01 ml/min. (19). In this study, 
it was observed that of the 40 patients who reported xe-
rostomia after radiotherapy, practically all of them had 
reduced salivary flow and half of the sample presented 
salivary flow equal to zero. This demonstrates that hy-
posalivation is an important factor associated with the 
sensation of buccal dryness described by patients re-
ceiving radiation therapy to the head and neck.
The literature shows that the reduction of salivary se-
cretion can translate beyond xerostomia into oral dis-
comfort, altered taste, difficulties in speech, chewing, 
swallowing and increased risk of dental caries and sec-
ondary infections (7). Our data are in agreement with 
the literature, when a good part of the sample presented 
candidiasis and more than half developed caries of ra-
diation. Carvalho et al. show that salivary flow altera-
tions induced by radiotherapy of the head and neck are 
the main responsible for a cariogenic environment, and 
caries of radiation can occur even in teeth not exposed 
to radiation (21).
The present study aimed to evaluate xerostomia through 
three parameters, the first one related to subjective feel-
ing through the Xerostomia Inventory (XI), the second 
relating xerostomia to quality of life through the OHIP-
14 questionnaire and the third, using clinical evidence 
of hypofunction of the salivary gland, using sialometry 
as an objective measure. According to Sasportas et al. 
these three parameters are important in the evaluation 
of a patient with xerostomia, because despite several 
methods described in the literature to standardize a 
classification for xerostomia, clinical evaluation often 
underestimates subjective severity, besides the fact that 
xerostomia is a condition which negatively affects the 
patient’s quality of life (4).
A study conducted in Canada, evaluating the quality of 
life related to oral health in patients with dry mouth, 
found that xerostomia had an important influence on 
well-being and quality of life (22). The present study 
demonstrated that there was influence between xerosto-
mia and patients’ quality of life, with a positive corre-
lation when Pearson’s correlation was performed. It is 
observed that the higher the degree of severity of the 
xerostomia, the worse the quality of life, corroborating 
with findings in the literature (4,6).
In this study, there was a statistically significant asso-
ciation with the time of conclusion of radiotherapy in 
the categorized time analysis, with a greater impact of 
xerostomia after 6 months and 18 months. Radiation-
induced xerostomia is the most prevalent and prominent 
long-term side effect in patients after radiation in the 
head and neck region, and it is usually related to a de-
crease in the patient’s quality of life (23).
Analyzing the distribution of the questions related 
to the quality of life of the oral health impact profile 
(OHIP-14) of the patients investigated, we observed that 
questions 2 (“Did you feel that the taste of food has got-
ten worse?”), 4 (“Did you feel uncomfortable eating any 
food? “) and 7 (“Has your food intake gotten impaired?”) 
were those with a higher frequency of answers “always” 
or “repeatedly” among the patients. This reflects in the 
analysis by domains where the highest scores, and con-
sequently a worse quality of life, are in the domains re-
lated to functional limitation, physical pain and physi-
cal disability. In a study by Niklander et al., observing 
risk factors, hyposalivation and oral health impact on 
quality of life, found that patients with xerostomia ob-
tained higher scores in all OHIP-14 domains comparing 
to control patients, with greater impact on the domains 
related to psychological discomfort, psychological inca-
pacity and physical pain (24).
As already mentioned, the results of this study demon-
strated that xerostomia in patients who underwent ra-
diotherapy in the head and neck region has an impor-
tant effect on quality of life. It is relevant to say that the 
treatments available for xerostomia are generally not 
effective; sialogogues have side effects and are not al-
ways efficient. The effects of saliva substitutes are lim-
ited and the level of patient satisfaction is generally low 
(6,25). Among the therapies that have been highlighting 
is the use of low power laser, for promoting biomodula-
e775
Med Oral Patol Oral Cir Bucal. 2019 Nov 1;24 (6):e770-5. Xerostomy and quality of life of patients submitted to head and neck radiotherapy
tion of cellular metabolism, analgesia and anti-inflam-
matory effects, without mutagenic and photothermal 
effects (18). Therefore, the prevention of radiation-in-
duced xerostomia can have a significant impact on long-
term quality of life. Intensity-modulated radiotherapy 
(IMRT) is described as a way of preventing or minimiz-
ing the degree of xerostomia, widely used as the most 
effective solution in terms of benefits (4,26). Sanguineti 
et al., have provided evidence that patients whose parot-
ids have a significantly reduced radiation dose during 
IMRT for oropharyngeal cancer will be less likely to 
be dependent on artificial saliva at 1 and 2 years post-
treatment (27). However, this type of radiotherapy treat-
ment is not yet a reality in all public network oncology 
services, in fact no patient in this study was treated with 
IMRT.
Conclusion
Based upon the results of the present study it is conclud-
ed that xerostomia has a negative impact on the quality 
of life of patients who undergo radiotherapy in the head 
and neck region.
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